Financial Advocates Investment Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-703
| Closed | -$6.07K | – | 723 |
|
|
2023
Q2 | $6.07K | Sell |
703
-126
| -15% | -$1.09K | ﹤0.01% | 692 |
|
|
2023
Q1 | $8.74K | Hold |
829
| – | – | ﹤0.01% | 728 |
|
|
2022
Q4 | $28.1K | Buy |
+829
| New | +$28.1K | ﹤0.01% | 736 |
|
|
2022
Q3 | – | Sell |
-829
| Closed | -$47K | – | 798 |
|
|
2022
Q2 | $47K | Sell |
829
-1,117
| -57% | -$63.3K | ﹤0.01% | 667 |
|
|
2022
Q1 | $157K | Sell |
1,946
-5,416
| -74% | -$437K | 0.01% | 694 |
|
|
2021
Q4 | $1.76M | Buy |
7,362
+5,894
| +401% | +$1.41M | 0.11% | 215 |
|
|
2021
Q3 | $409K | Buy |
1,468
+311
| +27% | +$86.6K | 0.03% | 519 |
|
|
2021
Q2 | $328K | Buy |
+1,157
| New | +$328K | 0.02% | 582 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 766 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 654 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 614 |
|
|
2020
Q1 | – | Sell |
-945
| Closed | -$538K | – | 520 |
|
|
2019
Q4 | $538K | Buy |
945
+151
| +19% | +$86K | 0.06% | 298 |
|
|
2019
Q3 | $217K | Buy |
+794
| New | +$217K | 0.02% | 442 |
|